Skip to main content
. 2025 Aug 11;16:1614678. doi: 10.3389/fneur.2025.1614678

Figure 2.

Flowchart depicting patient selection process for a study. Starting with 234 eligible patients, inclusion criteria are outlined: no prior treatment before glioma diagnosis, possession of postoperative histopathological findings, and confirmation of grade 3 or 4 glioma. Exclusions are due to lack of histopathological reports (108), insufficient resolution (5), or missing longitudinal data (41). The total study population is 80, split into a training set of 56 and a testing set of 24.

Flow chat of patient selection.